{"id":26362,"date":"2026-08-06T07:50:34","date_gmt":"2026-08-06T11:50:34","guid":{"rendered":"https:\/\/medicarereport.org\/?p=26362"},"modified":"2026-08-06T07:50:35","modified_gmt":"2026-08-06T11:50:35","slug":"part-d-costs-on-the-rise-due-to-iras-benefit-redesign","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=26362","title":{"rendered":"Part D Costs on the Rise Due to IRA&#8217;s Benefit Redesign"},"content":{"rendered":"\n<p>The Congressional Budget Office (CBO) has projected that Medicare Part D will cost $400 billion more than its immediate post-IRA (The Inflation Reduction Act) estimate and $150 billion more than before the IRA&#8217;s enactment. The higher-than-expected cost of the IRA\u2019s Part D redesign is the main contributor to the cost increase, which has also been boosted by higher inflation, the introduction and expanded use of newer drugs like GLP-1s, and other factors. To read The Committee for a Responsible Federal Budget report, click <a href=\"https:\/\/www.crfb.org\/blogs\/part-d-costs-rise-due-iras-benefit-redesign\" data-type=\"link\" data-id=\"https:\/\/www.crfb.org\/blogs\/part-d-costs-rise-due-iras-benefit-redesign\">here\u2026<\/a><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>\u00a0The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Congressional Budget Office (CBO) has projected that Medicare Part D will cost $400 billion more than its immediate post-IRA<\/p>\n","protected":false},"author":4,"featured_media":10021,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1066,21,15],"tags":[80,385,238,184,65],"class_list":["post-26362","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-congressional-budget-office-cbo","category-health-care-finance","category-part-dprescription-drugs","tag-cms","tag-healthcare-costs","tag-healthcare-finance","tag-inflation-reduction-act","tag-medicare-part-d"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/26362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26362"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/26362\/revisions"}],"predecessor-version":[{"id":26363,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/26362\/revisions\/26363"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/media\/10021"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}